These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 19406958

  • 1. In crescentic IgA nephropathy, fractional excretion of IgG in combination with nephron loss is the best predictor of progression and responsiveness to immunosuppression.
    Bazzi C, Rizza V, Raimondi S, Casellato D, Napodano P, D'Amico G.
    Clin J Am Soc Nephrol; 2009 May; 4(5):929-35. PubMed ID: 19406958
    [Abstract] [Full Text] [Related]

  • 2. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 May; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 3. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009 May; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 4. Urinary IgG and α2-macroglobulin are powerful predictors of outcome and responsiveness to steroids and cyclophosphamide in idiopathic focal segmental glomerulosclerosis with nephrotic syndrome.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Gallieni M, D'Amico G.
    Biomed Res Int; 2013 May; 2013():941831. PubMed ID: 24093110
    [Abstract] [Full Text] [Related]

  • 5. Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, Pisano L, D'Amico G.
    Am J Kidney Dis; 2001 Aug; 38(2):240-8. PubMed ID: 11479148
    [Abstract] [Full Text] [Related]

  • 6. Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-β-D-glucosaminidase in glomerulonephritis.
    Bazzi C, Rizza V, Olivieri G, Casellato D, D'Amico G.
    J Nephrol; 2015 Oct; 28(5):541-8. PubMed ID: 25227764
    [Abstract] [Full Text] [Related]

  • 7. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
    Branten AJ, Klasen IS, Wetzels JF.
    Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
    [Abstract] [Full Text] [Related]

  • 8. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
    Tumlin JA, Lohavichan V, Hennigar R.
    Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
    [Abstract] [Full Text] [Related]

  • 9. Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study.
    Lv J, Yang Y, Zhang H, Chen W, Pan X, Guo Z, Wang C, Li S, Zhang J, Zhang J, Liu L, Shi S, Wang S, Chen M, Cui Z, Chen N, Yu X, Zhao M, Wang H.
    J Am Soc Nephrol; 2013 Dec; 24(12):2118-25. PubMed ID: 24029421
    [Abstract] [Full Text] [Related]

  • 10. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
    Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G.
    Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M, Bonerba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2015 Aug 03; (8):CD003965. PubMed ID: 26235292
    [Abstract] [Full Text] [Related]

  • 12. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF.
    Nephrol Dial Transplant; 2011 Nov 03; 26(11):3581-8. PubMed ID: 21467131
    [Abstract] [Full Text] [Related]

  • 13. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP, van den Brand JA, Wetzels JF.
    Neth J Med; 2009 Feb 03; 67(2):54-61. PubMed ID: 19299847
    [Abstract] [Full Text] [Related]

  • 14. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
    Walsh M, Sar A, Lee D, Yilmaz S, Benediktsson H, Manns B, Hemmelgarn B.
    Clin J Am Soc Nephrol; 2010 Mar 03; 5(3):425-30. PubMed ID: 20089495
    [Abstract] [Full Text] [Related]

  • 15. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D, Wang F, Ding J, Xiao H, Zhong X, Liu X.
    Zhonghua Er Ke Za Zhi; 2015 Sep 03; 53(9):670-5. PubMed ID: 26757967
    [Abstract] [Full Text] [Related]

  • 16. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G.
    Nephrol Dial Transplant; 2002 Nov 03; 17(11):1890-6. PubMed ID: 12401843
    [Abstract] [Full Text] [Related]

  • 17. Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness.
    Bazzi C, Rizza V, Casellato D, Tofik R, Berg AL, Gallieni M, D'Amico G, Bakoush O.
    BMC Nephrol; 2014 May 08; 15():74. PubMed ID: 24886340
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.